Differential impacts of fat and muscle mass on cardiovascular and non‐cardiovascular mortality in individuals with type 2 diabetes
Journal of Cachexia, Sarcopenia and Muscle · 2024
DOI: 10.1002/jcsm.13542 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, 2024. Verfasst von Jie Guo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Health, China Agricultural University, Beijing, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Cardiovascular Diseases. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lindhés Advokatbyrå AB, China Scholarship Council, Strategic Research Area Neuroscience (StratNeuro) at Karolinska Institutet.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
The distribution of fat and muscle mass in different regions of the body can reflect different pathways to mortality in individuals with diabetes. Therefore, we investigated the associations between whole‐body and regional body fat and muscle mass with cardiovascular disease (CVD) and non‐CVD mortality in type 2 diabetes (T2D).
Methods
Within the National Health and Nutrition Examination Survey 1999–2006, 1417 adults aged ≥50 years with T2D were selected. Dual‐energy X‐ray absorptiometry was used to derive whole‐body, trunk, arm, and leg fat mass and muscle mass indices (FMI and MMI). Mortality data until 31 December 2019 were retrieved from the National Death Index. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated from Cox proportional hazard models.
Results
A total of 1417 participants were included in this study (weighted mean age [standard error]: 63.7 [0.3] years; 50.5% female). Over a median follow‐up of 13.6 years, 797 deaths were recorded (371 CVD‐related and 426 non‐CVD deaths). Higher FMI in the arm was associated with increased risk of non‐CVD mortality (fourth quartile [Q4] vs. first quartile [Q1]: HR 1.82 [95% CI 1.13–2.94]), whereas higher FMI in the trunk or leg was not significantly associated with CVD or non‐CVD mortality. Conversely, higher arm MMI was associated with a lower risk of both CVD (Q4 vs. Q1: HR 0.51 [95% CI 0.33–0.81]) and non‐CVD (Q4 vs. Q1: HR 0.56 [95% CI 0.33–0.94]) mortality. There was a significant interaction between smoking status and arm FMI on non‐CVD mortality ( P for interaction = 0.007). Higher arm FMI was associated with a higher risk of non‐CVD mortality among current or former smokers (Q4 vs. Q1: HR 2.67 [95% CI 1.46–4.88]) but not non‐smokers (Q4 vs. Q1: HR 0.85 [95% CI 0.49–1.47]).
Conclusions
Fat mass and muscle mass, especially in the arm, are differently associated with CVD and non‐CVD mortality in people with T2D. Our findings underscore the predictive value of body compositions in the arm in forecasting mortality among older adults with T2D.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nutrition and Health, China Agricultural University, Beijing, China.
- Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Solna, Sweden.
- Institute of Environmental Medicine, Karolinska Institutet, Solna, Sweden.
- Medical Epidemiology, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
- Department of Physical Activity and Health, The Swedish School of Sport and Health Sciences (GIH), Stockholm, Sweden.
- Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden.
ORCID-Profile: Jie Guo
Förderung
- Lindhés Advokatbyrå AB
- China Scholarship Council
- Strategic Research Area Neuroscience (StratNeuro) at Karolinska Institutet
- Centrum för innovativ medicin
- Gamla Tjännarinor Foundation
- Loo och Hans Ostermans Foundation
- Foundation for Geriatric Diseases at Karolinska Institutet
- Loo och Hans Ostermans Stiftelse för Medicinsk Forskning
Zitieren
APA
Guo, J., Wei, Y., Heiland, E. G., & Marseglia, A. (2024). Differential impacts of fat and muscle mass on cardiovascular and non‐cardiovascular mortality in individuals with type 2 diabetes. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.13542
Vancouver
Guo J, Wei Y, Heiland EG, Marseglia A. Differential impacts of fat and muscle mass on cardiovascular and non‐cardiovascular mortality in individuals with type 2 diabetes. Journal of Cachexia, Sarcopenia and Muscle. 2024. doi:10.1002/jcsm.13542
BibTeX
@article{Guo2024,
author = {Guo, Jie and Wei, Yuxia and Heiland, Emerald G and Marseglia, Anna},
title = {Differential impacts of fat and muscle mass on cardiovascular and non‐cardiovascular mortality in individuals with type 2 diabetes},
journal = {Journal of Cachexia, Sarcopenia and Muscle},
year = {2024},
doi = {10.1002/jcsm.13542}
}
EUVIMED